Dragon Pharma Bronchogen 20 mg is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic tetrapeptide Bronchogen at a labeled strength of 20 mg/vial. Product specifications, storage information, and other practical product details are provided below.
20 mg/Vial Strength
Each vial is labeled at 20 mg of Bronchogen peptide.
2 mL Vial
Supplied as a lyophilized powder in a sealed 2 mL vial.
Lyophilized Form
Supplied as a freeze-dried powder for reconstitution with bacteriostatic water or suitable diluent.
Dragon Pharma
Manufactured and packaged under the Dragon Pharma product line.
Product Specifications
Product name
Bronchogen 20 mg
Active substance
Bronchogen
Labeled strength
20 mg/vial
Container
2 mL vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Products
Other research peptides available from Dragon Pharma include KPV 5 mg, a peptide investigated for its anti-inflammatory properties, and DSIP 10 mg, a peptide related to sleep regulation research. Each has a distinct research profile and mechanism of action.
Science & Research
Understanding Bronchogen
Bronchogen is a synthetic tetrapeptide composed of four amino acids — alanine, glutamic acid, aspartic acid, and leucine (AEDL). It is classified as a Khavinson-type peptide bioregulator, a class of short peptides known for their potential to interact with chromatin and influence gene expression in specific tissues.
1
Peptide Bioregulator
Bronchogen is a short tetrapeptide (AEDL) classified as a Khavinson-type peptide bioregulator, designed to influence cellular function in specific tissues.
2
Gene Expression Modulation
Khavinson-type peptides are researched for their potential to interact with chromatin and influence gene expression in a tissue-specific manner.
3
Respiratory Research Focus
Bronchogen is specifically researched for its potential to support bronchial epithelial tissue and lung health through epigenetic mechanisms.
Mechanism of Action
Bronchogen is a synthetic tetrapeptide (Ala-Glu-Asp-Leu) that belongs to the Khavinson class of peptide bioregulators. These short peptides are characterized by their small size and potential to interact with chromatin, influencing gene expression at the transcriptional level.
Khavinson-type peptides are named after the researcher who developed them and are the subject of ongoing investigation into their potential to support tissue-specific functions. Bronchogen's amino acid sequence is specifically associated with research into respiratory tissue and bronchial epithelial support.
Research Context
Bronchogen is researched for its potential to reduce inflammation in lung tissue and support the repair of bronchial epithelial cells. These mechanisms are of interest in the study of respiratory health, where tissue repair and inflammatory modulation are important considerations.
Dragon Pharma Bronchogen 20 mg is supplied as a lyophilized powder in a 2 mL vial at a labeled strength of 20 mg/vial.
Research References
Bronchogen and related Khavinson-type peptides have been the subject of preclinical research investigating their properties and potential applications.
Bronchogen is a research peptide with limited safety data in humans. As a peptide bioregulator that may influence gene expression and tissue function, its use requires appropriate consideration of potential physiological effects.
Respiratory Considerations
Bronchogen is researched for its effects on bronchial epithelium and lung tissue. Individuals with pre-existing respiratory conditions should exercise caution.
Injection Site Reactions
Reconstituted peptides may cause localized reactions at the injection site. Proper aseptic technique is essential for preparation and administration.
Gene Expression Effects
As a peptide bioregulator, Bronchogen may influence gene expression through chromatin interaction. The full scope of these effects is not fully characterized.
Pregnancy and Breastfeeding
Bronchogen is not indicated for use during pregnancy or breastfeeding. Its effects on fetal development and infant health are not established.
Conditions That Require Medical Review
Medical advice is particularly important when there is a history of respiratory conditions, autoimmune disorders, or when taking medications that may interact with immune or inflammatory pathways.
The product should also be stored securely to prevent accidental access or use by children or other household members.
When to Seek Urgent Medical Help
Seek urgent medical attention for symptoms such as severe allergic reactions, difficulty breathing, chest pain, sudden shortness of breath, or signs of a serious adverse reaction.
Tested Sport
Bronchogen is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Quick answers about Bronchogen 20 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma Bronchogen 20 mg?
Dragon Pharma Bronchogen 20 mg is a lyophilized peptide product containing Bronchogen at a labeled strength of 20 mg per vial. It is supplied in a 2 mL vial as a freeze-dried powder.
What is Bronchogen?
Bronchogen is a synthetic tetrapeptide (Ala-Glu-Asp-Leu, or AEDL) belonging to the Khavinson class of peptide bioregulators. It is researched for its potential to interact with chromatin and influence gene expression related to lung and bronchial tissue.
How is Bronchogen 20 mg supplied?
It is supplied as a lyophilized powder in a 2 mL vial. The product must be reconstituted with a suitable diluent such as bacteriostatic water before use in a research setting.
What is a Khavinson-type peptide bioregulator?
Khavinson-type peptide bioregulators are short synthetic peptides (typically 2-4 amino acids) that are researched for their potential to interact with chromatin and influence gene expression in a tissue-specific manner. They are named after the researcher who developed them.
Is Bronchogen 20 mg FDA approved?
No. Bronchogen is not FDA-approved for any therapeutic use. It is a research compound intended for laboratory and preclinical research purposes only.
How should Bronchogen 20 mg be stored?
Keep the lyophilized powder in its original packaging and protect it from excessive heat, moisture and direct light. Refer to the product label for specific storage directions regarding temperature and shelf life. Once reconstituted, the solution should be used promptly or stored according to the manufacturer's directions.
Does Bronchogen 20 mg require refrigeration?
Follow the storage instructions printed on the supplied product. Lyophilized peptides often require refrigeration, but specific storage conditions should be verified from the product label.
How long does Bronchogen 20 mg delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy Bronchogen 20 mg with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Bronchogen 20 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is Bronchogen permitted in tested sport?
Bronchogen is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find more information about Bronchogen?
Additional information about Bronchogen and Khavinson-type peptides is available through PubMed and other research literature databases. Direct links are provided in the Science & Research section above.
